A randomized, open-label study to evaluate efficacy and safety of ombitasvir/paritaprevir/ritonavir co-administered with ribavirin in adults with genotype 4 chronic hepatitis C infection and cirrhosis.

Asselah T, Hassanien T, Qadish RB, al. et. A randomized, open-label study to evaluate efficacy and safety of ombitasvir/paritaprevir/ritonavir co-administered with ribavirin in adults with genotype 4 chronic hepatitis C infection and cirrhosis. Journal of Hepatology. 2015;62(S861).

Publication Type:

Journal Article

Authors:

Asselah, T.; Hassanien, T.; Qadish, R.B.; et al.

Source:

Journal of Hepatology, Volume 62, Issue S861 (2015)

Cited On:

Export Citation:
RIS Format
Top